Zymeworks
Tong Ding is a Senior Research Associate at Zymeworks Inc. since February 2017, specializing in analytical support for protein and antibody-drug conjugate (ADC) projects through advanced LC/LC-MS techniques. Key contributions include characterization of protein purity, assessment of ADC conjugation reactions, and evaluation of stability and pharmacokinetics. Prior experience includes a role as Research Associate at Zymeworks, focusing on ADC characterization through LC MS analysis, and as a Research and Development Scientist at Viva Pharmaceutical Inc., managing stability programs for pharmaceuticals and conducting research on Traditional Chinese Medicines. Tong Ding holds a Master of Science in Chemistry and a Bachelor of Science in Chemistry, both from the University of British Columbia.
Zymeworks
2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.